Summary: Women make up nearly two-thirds of Alzheimer’s patients, and researcher may have just discovered a massive reason why. A new study found that when the protein alpha-synuclein (typically ...

The findings suggest that when alpha-synuclein -- a protein associated with Parkinson's and other Lewy body diseases -- accumulates alongside Alzheimer's pathology, it may drive faster Alzheimer's ...

A new study from researchers at Mayo Clinic offers an important clue. The study suggests that a protein linked to Parkinson’s disease may play a major role in speeding up Alzheimer’s‑related brain ...

Alpha-synuclein oligomers play a key role in the development and progression of the disease and, therefore, are promising therapeutic and diagnostic targets, particularly in the early stages of the ...

SynuSight Biotech has licensed 18F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment ABLi will leverage the ability ...

Aplp1's bond with Lag3 on the cell's surface enables healthy brain cells to absorb traveling clumps of alpha-synuclein, leading to cell death, the researchers say. In mouse studies published in 2016 ...